Table 1.
Sample | Clean paired reads | Clean bases (G) | Q20 (%) | Q30 (%) | GC content (%) | Clean data ratio (%) |
---|---|---|---|---|---|---|
CK1 | 16,904,798 | 4.94 | 99.16 | 96.6 | 53.74 | 93.79 |
CK2 | 22,009,157 | 6.4 | 98.94 | 95.91 | 53.49 | 91.62 |
CK3 | 21,485,183 | 6.23 | 99.08 | 96.36 | 53.48 | 92.56 |
MHT1 | 26,032,345 | 7.57 | 98.95 | 95.89 | 53.43 | 91.92 |
MHT2 | 23,893,148 | 6.94 | 99.03 | 96.14 | 53.5 | 91.95 |
MHT3 | 23,676,604 | 6.87 | 98.96 | 95.94 | 53.18 | 91.35 |
SHT1 | 26,241,571 | 7.61 | 99.04 | 96.18 | 53.48 | 91.52 |
SHT2 | 23,261,438 | 6.74 | 99.16 | 96.59 | 53.44 | 92.86 |
SHT3 | 23,375,530 | 6.79 | 98.97 | 95.94 | 53.32 | 91.56 |
CK1, CK2 and CK3: three independent biological replicates of Control
MHT1, MHT2 and MHT3: three independent biological replicates of group MHT
SHT1, SHT2 and SHT3: three independent biological replicates of group SHT
Q20: the percentage of bases with a Phred score over 20
Q30: the percentage of bases with a Phred score over 30